Search results
What are the new COVID FLiRT variants, and are they in Wisconsin?
Milwaukee Journal Sentinel via Yahoo News· 7 days agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
Wisconsin Supreme Court's liberal justices appear poised to flip ballot drop box ban
Wisconsin State Journal· 2 days agoThe state's high court on Monday heard oral arguments in a case backed by Democratic groups who...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 18 hours agoPfizer Pfizer (NYSE: PFE) is one of the world's leading pharmaceutical companies, but it's fallen...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 12 hours agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19...
REPUBLICAN RUNOFF 2024 | Texas House District 1 Representative | Texarkana Gazette
Texarkana Gazette· 1 day agoRepublicans will choose between Texas House District 1 incumbent Rep. Gary VanDeaver and challenger...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges By Investing.com
Investing.com· 2 days agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...
Chief medical officer denies straying into political issues during pandemic
Press Association News via AOL· 5 days agoA full transcript of today’s hearing will be available on the website shortly with an accessible...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 7 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Morningstar· 5 days ago(NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers, today